Funder: American Academy of Neurology
Due Dates: December 17, 2026 (MdDS and Central Vestibular Disorders, extended) | January 7, 2027 (Epilepsy, extended)
Funding Amounts: Two years for ALS and ALS and Related Disorders; three years for Richard Olney Clinician Scientist
Summary: The American Brain Foundation supports early-career neurological research through disease-specific awards and investigations relevant to multiple conditions.
Key Information: Applicants typically must have completed residency or a PhD within five years before funding begins, or seven years for Richard Olney ALS.
Description
The American Brain Foundation’s Next Generation Research Grants support innovative neurological investigations by early-career researchers and help launch academic careers in neurological research. The program combines disease-specific awards, supported by condition-focused funding partners, with general research that has potential relevance to more than one condition. The American Academy of Neurology collaborates on the cognitive aging, Parkinson’s disease, and stroke awards.
Research areas span ALS and related disorders, ASXL-related neurodevelopmental diseases, cognitive aging, epilepsy, neuromuscular disease, Parkinson’s disease, peripheral neuropathy, stroke, and Mal de Débarquement syndrome and central vestibular disorders. General research priorities include mental health and neuropsychiatry, women’s health, prevention and resilience, and Alzheimer’s and dementia.
